SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTialis Essen It Regulatory News (TIA)

Share Price Information for Tialis Essen It (TIA)

Share Price is delayed by 15 minutes
Get Live Data
50.50    0.00 (0.00%)
Bid:
50.00
Ask:
51.00
Spread: 1.00 (2.00%)
Market Cap: £20.15m
TIA Live PriceLast checked at - London Stock Exchange

Intraday Tialis Essen It Share Chart

MXC Distribution, Trading Update and Board Changes

30 Jan 2026 14:44

RNS Number : 1538R
Tialis Essential IT PLC
30 January 2026
Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms partΒ of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Β 

Β 

30 January 2026

Tialis Essential IT Plc

("Tialis" or the "Company")

Β 

Response to liquidation of MXC Capital Limited, distribution of its shareholding in Tialis trading update for the year ended 31 December 2025 and Board Changes

Β 

Tialis Essential IT Plc (AIM: TIA), the AIM‑quoted provider of essential IT services, has been made aware that MXC Capital Limited ("MXC"), the Company's largest shareholder, has placed MXC into members' voluntary liquidation and intends to distribute its assets to its shareholders.

As part of the liquidation, MXC intends to distribute its entire shareholding in Tialis, representing approximately 67.17 per cent. of the Company's issued share capital, to MXC shareholders, conditional on the completion of the liquidation process and compliance with applicable legal and regulatory requirements (the "Distribution").

Following completion of the liquidation, MXC has advised the Company that MXC shareholders will receive distributions comprising Tialis ordinary shares plus cash in accordance with the terms of the liquidation. Under the terms of the distribution, all MXC shareholders will receive the same allocation of shares and cash.

The completion of the liquidation process is expected to take place on 2 March 2026, and the Distribution will happen shortly thereafter.

Impact on Tialis

When the Distribution takes place:

Β· MXC will cease to be a shareholder in the Company;

Β· Tialis' share register will become more diversified, with Tialis shares held directly by MXC's underlying shareholders; and

Β· The Company would expect this to increase the free float and liquidity of Tialis shares on AIM.

The Board does not expect the Distribution to have any operational impact on Tialis' business, strategy or employees.

Relationship with MXC

MXC has been a long-standing and supportive shareholder of Tialis and has contributed meaningfully to the Company's development during this period. The Board would like to record its thanks for MXC's continued support and engagement.

Following completion of the Distribution, any arrangements, understandings or rights which exist between the Company and MXC that are conditional on MXC's shareholding are expected to fall away following completion of the distribution.

Changes to the board

Tialis is pleased to announce that David Niall O'Regan ("Niall"), Chief Operating Officer, has joined the Board of the Company with immediate effect and has been promoted to Chief Executive Officer. Tialis also announces that Ian Smith has stepped down from his position as Executive Director with immediate effect in order to pursue other business interests. Ian will remain a director of AI Auxesis Limited.

Niall has been responsible for the Group's operational activities and has worked closely with the Executive Director and Chief Financial Officer to support the delivery of the Group's strategy and operational performance. Niall was appointed to the role in September 2024, having previously served as Commercial Director following the acquisition of certain profitable contracts from Allvotec. He has held several senior leadership roles at Allvotec, including Managing Director, and has over 25 years' experience in senior commercial, sales and operational roles across the technology, managed services, retail, hospitality, and leisure sectors.

Peter Hallett, current Non-Executive Director has been appointed as Interim Non-Executive Chairman.

Trading Update for the year ended 31 December 2025

Tialis gives an update on trading for the year ended 31 December 2025.

Financial Highlights

Group

Β· Revenue for the year is expected to be no less than Β£17m

Β· Adjusted EBITDA1 for the year is expected to be no less than Β£1.8m

Β· Repayment of the bank borrowings of Β£1m (2024: Β£nil)

Β· Β£8.2m invested during the year to support long‑term value creation and portfolio diversification through the acquisition of MXLG Acquisitions Limited ("MXLGA"), AI Auxesis Limited, CloudCoco Group Plc, Digital Petcare Direct Limited and QPC 2020 Limited

oΒ  MXLGA (50% joint venture investment) - Β£7.2m

oΒ  CloudCoCo Group Plc - Β£0.2m

oΒ  QPC 2020 Limited - Β£0.3m

oΒ  Digital Petcare Direct Limited - Β£0.5m

Β· Customer concentration risk reduced materially, with exposure from the largest customer declining from 81% (2024) to 60% (2025).

Β· Tialis enter 2026 with a current sales pipeline of Β£9m with 13 different partners

Joint venture

Β· MXLGA finished the year with expected revenue to be no less than Β£22m and adjusted EBITDA1 for the year is expected to be no less than Β£2.2m

Β· MXLGA enters 2026 with confirmed orders of Β£8.1m revenue and a pipeline revenue for Q1 2026 of Β£3.3m, reflecting advanced opportunities within existing customer demand.

Β 

1 Adjusted EBITDA excludes share-based payment charges along with depreciation, amortisation, interest, and tax from the measure of profit.

Β 

Β 

Β 

Β 

Peter Hallett, Interim Non-Executive Chairman, commented: "Tialis is supportive of MXC's proposal. The proposed distribution would result in a more diversified shareholder base for Tialis and is expected to improve liquidity in the Company's shares. We believe this will be beneficial both for existing shareholders and for those joining the register as a result of the distribution.

On behalf of the Board, I would like to thank Ian for his valuable support and contribution to Tialis over a number of years. We wish him every success in his future endeavours.

We are delighted to welcome Niall to the Board, having already benefitted significantly from his experience and expertise in his prior role as Chief Operating Officer."

For more information, contact:

Tialis Essential IT Plc

Peter Hallett, Interim Non-Executive Chairman

Tel: +44 (0)344 874 1000

Cavendish Capital Markets Ltd

Nominated Adviser and Broker

Corporate Finance: Jonny Franklin-Adams/ Elysia Bough

Corporate Broking: Tim Redfern

Tel: +44 (0)20 7220 0500

Β 

Further regulatory disclosures relatingΒ to a director appointment

Other than as disclosed below, there are no further disclosures to be made in accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.

Β 

Full Name: David Niall O'Regan

Age: 58

Β 

Current Directorships / Partnerships:

Β· Tialis Essential IT Financing Limited

Β· Tialis Essential IT Manage Limited

Β 

Previous Directorships / Partnerships (held in the past five years)

None in last 5 years

Β 

Niall does not hold any shares in the Company.Β Niall holds 53,825 options over ordinary shares of 1p each Tialis Essential IT plc which represent 0.13% of the Company's ordinary issued share capital.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDEALFEDLAKEFA
12
Date   Source Headline
12th May 20267:00 amRNSFinal Results and Notice of AGM
23rd Mar 20268:50 amRNSHolding(s) in Company
18th Mar 20262:20 pmRNSHolding(s) in Company
17th Mar 20267:01 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSHolding(s) in Company
13th Mar 20264:32 pmRNSHolding(s) in Company
10th Mar 20264:11 pmRNSHolding(s) in Company
10th Mar 20264:11 pmRNSHolding(s) in Company
10th Mar 20264:10 pmRNSHolding(s) in Company
10th Mar 20264:10 pmRNSHolding(s) in Company
30th Jan 20262:44 pmRNSMXC Distribution, Trading Update and Board Changes
28th Jan 20263:43 pmRNSHolding(s) in Company
28th Jan 20263:40 pmRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
13th Oct 20257:00 amRNSDirector Dealing
8th Oct 20255:05 pmRNSHolding(s) in Company
8th Oct 20255:02 pmRNSHolding(s) in Company
8th Oct 20253:01 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSChange of Directorate
7th Oct 20251:45 pmRNSCompletion of Acquisition of stake in MXLG
3rd Oct 202511:54 amRNSResult of General Meeting and Total Voting Rights
12th Sep 20257:00 amRNSNotice of GM and Related Party Transaction
9th Sep 20257:00 amRNSUnaudited Interim Results
8th Sep 20257:00 amRNSAppointment of Independent Non-Executive Directors
5th Sep 20257:00 amRNSDelivery of Material Contract Commenced
2nd Sep 20257:00 amRNSSignificant Contract Expansion
13th Aug 20255:44 pmRNSHolding(s) in Company
3rd Jul 20252:32 pmRNSHolding(s) in Company
2nd Jul 20253:17 pmRNSLoan Refinancing
1st Jul 20252:09 pmRNSStrategy Update and Issue of Equity
20th Jun 202511:15 amRNSResult of Annual General Meeting
12th May 20257:00 amRNSFinal Results and Notice of AGM
8th May 20257:00 amRNS-RAI Auxesis announces strategic investment in QPC
9th Apr 20257:00 amRNSNew Subsidiary and Issue of Equity
21st Jan 20257:00 amRNSContract Wins and Extensions
6th Jan 20257:00 amRNSTrading Update
15th Nov 20242:13 pmRNSHolding(s) in Company
13th Nov 20242:00 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirectorate Change
16th Sep 20247:00 amRNSAppointment of Chief Financial Officer as Director
10th Sep 20247:00 amRNSInterim Results, Related Party Loan, Board Changes
26th Jun 202410:45 amRNSResult of AGM
21st May 202412:29 pmRNSHolding(s) in Company
21st May 202412:29 pmRNSHolding(s) in Company
15th May 20247:00 amRNSIssue of Equity
10th May 20247:00 amRNSFinal Results and Notice of AGM
17th Jan 20247:00 amRNSTrading Update
18th Dec 20237:35 amRNSGrant of Options
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.